INDIANAPOLIS (WISH) — Lupus is a debilitating autoimmune disease that affects around 1.5 million Americans. Now, new research shows a therapy that’s been used for cancer patients may help people with ...

Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...

Test will help bridge detection gap for systemic lupus erythematosus, or SLE SEATTLE — Aug. 28, 2002 — The U.S. Food and Drug Administration has cleared for market a new screening test for lupus ...

The results of a study found a doubled risk of pre-malignant cervical changes, and potentially also an increased risk of cervical cancer, among women with Systemic Lupus Erythematosus (SLE) compared ...

In today’s ACT Brief, we examine why representative enrollment remains a barrier in US cancer trials, review Johnson & ...

Rheumatology — the study of immune-system-driven diseases of the bones, joints, muscles, and in-betweens — has inherited plenty of hand-me-downs from cancer research. For example, there are ways of ...

Researchers have devised a way to re-engineer lupus antibodies to turn them into potential cancer killers. Lupus is a chronic inflammatory disease that occurs when the immune system attacks its own ...

This is the fourth installment in a series on the advances CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” Here we draw attention to promising findings for CAR T lupus treatment.

People with lupus who tested positive for three or more different lupus autoantibodies have a significantly lower risk of developing breast cancer, according to a new study. Overall, people with lupus ...

Chimeric antigen receptor (CAR) T-cell therapy has been hailed as a major advance in clinical cancer care, and now researchers are testing the use of these products in other therapeutic areas, ...